"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments, and email. This allows you to still get great care while helping to address the community spread of COVID-19. If you’re concerned about your specific health condition, call 1-833-KP4CARE (1-833-574-2273) (TTY 711) to talk to a licensed care provider 24/7. For answers to your general questions about COVID-19, call our new information line for Kaiser Permanente members at 1-877-813-7297."

During the past decade, Kaiser Permanente Medical Office -Vandever Medical Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Medical Office -Vandever Medical Office" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 12 trials, followed by "NSABP Foundation Inc" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Eastern Cooperative Oncology Group" with 2 trials sponsored and "National Cancer Institute (NCI)" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Medical Office -Vandever Medical Office" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Aptuit" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Medical Office -Vandever Medical Office" are "Breast Cancer" (7 trials), "Colorectal Cancer" (5 trials), "Lymphoma" (5 trials), "Leukemia" (2 trials) and "Pain" (2 trials). Many other conditions were trialed in "Kaiser Permanente Medical Office -Vandever Medical Office" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Medical Office -Vandever Medical Office" are "Drug" (16 trials), "Biological" (11 trials), "Other" (7 trials), "Radiation" (3 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "rituximab" (5 trials), "bevacizumab" (4 trials), "placebo" (4 trials), "Placebo" (2 trials) and "capecitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Medical Office -Vandever Medical Office" are 19 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente Medical Office -Vandever Medical Office". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Kaiser Permanente Medical Office -Vandever Medical Office, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Medical Office -Vandever Medical Office, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".